The current PE ratio for Voyager Therapeutics stock as of Oct 24, 2024 is 25.29. This is calculated based on the current EPS of $0.26 and the stock price of $6.58 per share.
The average historical PE ratio of Voyager Therapeutics for the last nine years is 6.73. The current PE ratio of 25.29 is comparable to the historical average. Over the past nine years, VYGR's PE ratio was at its highest in the Jun 2024 quarter at 30.42, when the stock price was $7.91 and the EPS was $0.26. The lowest value was in the Sep 2016 quarter, when it reached 0.79 with a price of $12.01 and an EPS of $15.21.
Year | PE ratio | Change |
---|---|---|
2023 | 2.74 | N/A |
2022 | N/A | N/A |
2021 | N/A | N/A |
2020 | 7.22 | N/A |
2019 | N/A | N/A |
2018 | N/A | N/A |
2017 | N/A | N/A |
2016 | N/A | N/A |
2015 | N/A | N/A |
2014 | N/A | N/A |
Currently, VYGR's PE ratio is greater than its 3 and 5-year historical averages.
Compared to its peer stock ORMP, VYGR's PE ratio stands higher.
Stock name | PE ratio | Market cap |
---|---|---|
ORMP Oramed Pharmaceuticals Inc | 4.63 | $96.21M |
VYGR Voyager Therapeutics Inc | 25.54 | $362.1M |
OLMA Olema Pharmaceuticals Inc | N/A | $685.48M |
OMER Omeros Corp | N/A | $246.27M |
OMGA Omega Therapeutics Inc | N/A | $79.97M |
ONCT Oncternal Therapeutics Inc | N/A | $4.41M |
ONVO Organovo Holdings Inc | N/A | $7.24M |
ORIC Oric Pharmaceuticals Inc | N/A | $594.67M |
The price to earnings ratio for VYGR stock as of Oct 24, 2024, stands at 25.29.
The average PE ratio for VYGR stock over the past 3 years is 9.41.
The average PE ratio for VYGR stock over the past 5 years is 8.57.
The highest quarterly PE ratio in the last nine years has been 30.42 and it was in the Jun 2024 quarter.
The current price to earnings ratio of VYGR is 276% higher than the 9-year historical average.
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Oct 24, 2024), Voyager Therapeutics's stock price is $6.58. The earnings per share for the trailing twelve months (TTM) ending Jun 2024 is $0.26. Therefore, Voyager Therapeutics's P/E ratio for today is 25.29. PE RATIO(25.29) = STOCK PRICE($6.58) / TTM EPS($0.26)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.